期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Effect of Dexmedetomidine and Remifentanil on Renal Function in Patients Undergoing Bariatric Surgery 被引量:2
1
作者 Antonio Carlos Meinberg Joao Pedro Raduan Meinberg1] +7 位作者 Nathalia Simoes Artibale1] Pedro Thadeu Galvao Vianna1] Idiberto Jose Zotarelli Filho Discipline of Anesthesiology School of Medicine of Sao Jose do Rio Preto FAMERP Sao Jose do Rio Preto/SP Brazil 《Open Journal of Anesthesiology》 2020年第4期120-133,共14页
Background and Objectives: In anesthesia for bariatric surgery, alterations occur in several organs, including the kidney. The objective of this study was to compare the effect of dexmedetomidine and remifentanil on t... Background and Objectives: In anesthesia for bariatric surgery, alterations occur in several organs, including the kidney. The objective of this study was to compare the effect of dexmedetomidine and remifentanil on the renal function of morbidly obese patients submitted to bariatric surgery. Methods: Sixty-one patients were studied prospectively and divided randomly into two groups: remifentanil (R) and dexmedetomidine (D). Renal function was evaluated in three phases: before anesthesia (M0), after anesthetic induction (M1) and after surgical incision (M2). Plasma concentrations were determined for glucose, antidiuretic hormone, creatinine, urea, sodium, potassium and osmolarity and urinary concentrations for creatinine, urea, sodium, potassium and osmolarity. Results: Significant differences were found between groups for potassium at M1 (p Conclusions: In both groups, the clearance values fell from moments M0 to M2. This result indicates that renal function of obese patients submitted to bariatric surgery presented a physiological response compatible with the effect of anesthetic-surgical stress. In the group D, creatinine and sodium clearances were elevated at M1. Urinary volume was greater at M2. These results are suggestive of better preservation of renal function. 展开更多
关键词 Renal Function Bariatric Surgery DEXMEDETOMIDINE REMIFENTANIL
下载PDF
A new heparin fragment decreases liver ischemia-reperfusion injury
2
作者 Enio R Vasques Estela RR Figueira +10 位作者 Joel A Rocha-Filho Cinthia Lanchotte Jorge LS Ximenes Helena B Nader Ivarne LS Tersariol Marcelo A Lima Tiago Rodrigues JoséEM Cunha Eleazar Chaib Luiz AC D’Albuquerque Flávio HF Galvão 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2022年第2期190-192,共3页
To the Editor:Ischemia-reperfusion injury following surgery and transplantation can lead to irreversible multiorgan failure.Intracellular calcium overload is associated to cellular death during ischemiareperfusion.A r... To the Editor:Ischemia-reperfusion injury following surgery and transplantation can lead to irreversible multiorgan failure.Intracellular calcium overload is associated to cellular death during ischemiareperfusion.A recently discovered heparin fragment (HF),trisulfated disaccharide (TD),that acts on sodium-calcium exchanger(NCX) decreasing intracellular Ca^(2+),showed effectiveness on protecting hepatocytes from ischemia-reperfusion injury [1]. 展开更多
关键词 IRREVERSIBLE HEPARIN INJURY
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部